Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer
NCT04952480
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Small Cell Lung Cancer
Interventions
RADIATION:
Dose-escalated adaptive radiotherapy
DRUG:
Chemotherapy
Sponsor
AHS Cancer Control Alberta